Foamix Pharma Ord
(FOMX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 56,686 | 52,165 | 35,649 | 69,791 | 31,902 |
| Marketable Securities | 16,680 | 46,937 | 32,087 | 43,536 | 24,462 |
| Receivables | 1,692 | 2,065 | 1,768 | 3,674 | 785 |
| Inventories | 1,356 | N/A | N/A | N/A | N/A |
| TOTAL | $76,414 | $101,167 | $69,504 | $117,001 | $57,149 |
| Non-Current Assets | |||||
| PPE Net | 2,885 | 2,235 | 2,042 | 938 | 646 |
| Investments And Advances | 0 | 283 | 8,676 | 17,661 | 47,415 |
| Other Non-Current Assets | 1,860 | 46 | 32 | 35 | 35 |
| TOTAL | $4,745 | $2,564 | $10,750 | $18,634 | $48,096 |
| Total Assets | $81,159 | $103,731 | $80,254 | $135,635 | $105,245 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 20 | 507 |
| Accounts payable and accrued liabilities | 19,352 | 6,327 | 6,436 | 2,267 | 1,353 |
| Accrued Expenses | 3,381 | N/A | N/A | N/A | N/A |
| Other current liabilities | 5,501 | 4,141 | 3,730 | 2,984 | 2,169 |
| TOTAL | $29,326 | $10,468 | $10,228 | $5,271 | $4,058 |
| Non-Current Liabilities | |||||
| Long Term Debt | 32,725 | N/A | N/A | N/A | 20 |
| Deferred Revenues | N/A | N/A | 62 | N/A | 29 |
| Other Non-Current Liabilities | 1,533 | 1,081 | 1,425 | 379 | 365 |
| TOTAL | $34,258 | $1,081 | $1,425 | $379 | $385 |
| Total Liabilities | $63,584 | $11,549 | $11,653 | $5,650 | $4,443 |
| Shareholders' Equity | |||||
| Common Shares | 2,659 | 2,331 | 1,576 | 1,561 | 1,284 |
| Retained earnings | -310,587 | -215,409 | -141,281 | -75,566 | -46,230 |
| Other shareholders' equity | 5 | -43 | -58 | -62 | -130 |
| TOTAL | $17,575 | $92,182 | $68,601 | $129,985 | $100,802 |
| Total Liabilities And Equity | $81,159 | $103,731 | $80,254 | $135,635 | $105,245 |